Fulgent Genetics (FLGT) News Today

Millennium Management LLC grew its position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 34.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 958,852 shares of the

Algert Global LLC boosted its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 46.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,440 shares of the company's stock after acq

Caxton Associates LP acquired a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 25,095 shares of the company's stock, valued at approximat

Divisadero Street Capital Management LP raised its holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 46.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 505,212 shares of the company's stock after purchasing an additional 160

Acadian Asset Management LLC boosted its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 593.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 62,724 shares of the company's stock after acqui

Bank of New York Mellon Corp increased its position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 37.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 201,201 shares of the company's

Acuitas Investments LLC acquired a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 49,016 shares of the company's stock, valued at approximately $962,000.

Fulgent Genetics (NASDAQ:FLGT) Shares Gap Down to $25.06

Fulgent Genetics (NASDAQ:FLGT) updated its FY 2024 earnings guidance. The company provided EPS guidance of -0.300--0.300 for the period, compared to the consensus estimate of -0.920. The company also issued revenue guidance of $280.0 millionillion-$280.0 millionillion, compared to the consensus estimate of $280.2 millionillion.

Fulgent Genetics (NASDAQ:FLGT) Shares Up 5.2%

Fulgent Genetics (NASDAQ:FLGT) Sees Strong Trading Volume

Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 98.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 86,792 sha

Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 783,400 shares, an increase of 8.7% from the May 31st total of 720,900 shares. Currently, 4.1% of the company's stock are short sold. Based on an average daily volume of 159,300 shares, the short-interest ratio is currently 4.9 days.

Park West Asset Management LLC lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 23.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 424,783 shares of the company's stock after acquiring an additional 79,649 shares during t

Dimensional Fund Advisors LP boosted its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 11.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,447,153 shares of the company'

Victory Capital Management Inc. trimmed its holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 60.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 28,599 shares of the company's stock after selling 43,211

Fulgent Genetics (NASDAQ:FLGT) Trading 5.5% Higher

Mirae Asset Global Investments Co. Ltd. lowered its position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 57.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 43,794 shares of the company's stock after selling 59,588 shares du

Fulgent Genetics (NASDAQ:FLGT) Hits New 52-Week Low at $20.32

Fulgent Genetics (NASDAQ:FLGT) Reaches New 52-Week Low at $20.66

Fulgent Genetics (NASDAQ:FLGT) Sets New 52-Week Low at $21.20

Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 611,200 shares, an increase of 22.6% from the February 29th total of 498,400 shares. Approximately 3.2% of the company's shares are short sold. Based on an average daily trading volume, of 208,900 shares, the short-interest ratio is currently 2.9 days.